Condition
Multiple Anomalies
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Whole Exome Sequencing Wes
Related Conditions
Often studied with 9 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Whole Exome Sequencing Wes1
- Face2gene1
Active Sponsors
- Manchester University NHS Foundation Trust1
- FDNA Inc.1
- University of California, San Francisco1
Top Investigators
Manchester University NHS Foundation Trust
University of California, San Francisco
Related Conditions
- Gastrointestinal Anomalies1
- Genitourinary Anomalies1
- Inborn Errors Of Metabolism1
- Thorax Anomalies1
- Skeletal Anomalies1